Workflow
Royalty Pharma: Investor Day Upside (NASDAQ:RPRX)

Following Royalty Pharma plc's (NASDAQ: RPRX ) Investor Day , we return with our commentary on the company. We have reviewed the Q2 results and continue to recommend a Buy rating, supported by consistent execution and anBuy-side hedge professionals conducting fundamental, income oriented, long term analysis across sectors globally in developed markets. Please shoot us a message or leave a comment to discuss ideas.DISCLOSURE: All of our articles are a matter of opinion, informed as they might be, and must be ...